| Selective treatment algorithm for mitral valve annuloplasty in nonischemic functional mitral regurgitation. | |
| | |
MedLine Citation:
|
PMID: 19398083 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The success rate of mitral annuloplasty (MA) for functional mitral regurgitation (FMR) varies. This study evaluated the effectiveness of this procedure in nonischemic dilated cardiomyopathy (DCM) patients after a selective treatment protocol was followed. METHODS AND RESULTS: This study analyzed 42 patients with nonischemic DCM and FMR (mean regurgitation grade, 3.6 +/- 0.3), aged a mean 56.5 +/- 15 years (range, 25 to 78 years), who underwent MA from April 2003 to December 2007. The analysis excluded patients with coronary artery disease, or mitral leaflets or subvalvular pathologies. All patients had taken maximal medications for at least 3 months and were still in New York Heart Association (NYHA) functional class III to IV (mean, 3.2 +/- 0.4). Mean ejection fraction (EF) was 31.4% +/- 12.9% (range, 8% to 58%), and left ventricular end-diastolic diameter (LVEDD) was 66.0 +/- 8.3 mm (range, 55 to 85 mm). Downsized Carpentier Physio ring (Carpentier-Edwards, Irvine, California) annuloplasty, mean size 26.3 +/- 2.3 (range, 24 to 30), was the preferred procedure. Concomitant procedures included 23 tricuspid valve repairs and 10 Maze operations for atrial fibrillation. Echocardiography was performed at early (<or=3 months; mean 1.6 +/- 1.5), short-term (6 to 12 months; mean 6.9 +/- 3.4), and midterm (>12 months; mean 29.5 +/- 13.4 months) follow-up. All late deaths and readmissions were recorded. One (2.4%) in-hospital death occurred due to low cardiac output. Follow-up was completed in 40 of 41 (97.6%) patients (mean duration, 31.9 +/- 16.1; range, 3.9 to 59.2 months). Eight (19.5%) patients were readmitted for heart failure, including 2 late MRs due to ring dehiscence and infective endocarditis. Three of 5 deaths during the follow-up period were attributed to cardiac death. Actuarial survival after 1 and 3 years was 88.9% and 79.2%, respectively. The number of patients treated with beta-blockers increased after operation, from 52.4% to 75.6% (P = .028). NYHA class decreased from 3.2 +/- 0.4 to 1.3 +/- 0.6 (P < .0001). Echo examination revealed left heart reverse remodeling and improved performance in all follow-up time frames. CONCLUSION: This study shows that MA in patients with non-ischemic DCM and FMR is feasible and associated with reasonable short and long term outcomes. |
| | |
Authors:
|
Shao-Wei Chen; Feng-Chun Tsai; Feng-Chang Tsai; Chun-Chi Chen; Chun-Li Wang; Mon-Yue Wu; Yao-Kuang Huang; Jaw-Ji Chu; Pyng Jing Lin |
Related Documents
:
|
19843203 - Immediate and long-term outcome of redo percutaneous mitral valvuloplasty: comparison w... 11509283 - The double-orifice technique for mitral valve reconstruction: predictors of postoperati... 21794113 - Communication patterns in a psychotherapy following traumatic brain injury: a quantitat... |
Publication Detail:
|
Type: Comparative Study; Journal Article Date: 2008-12-23 |
Journal Detail:
|
Title: Journal of cardiac failure Volume: 15 ISSN: 1532-8414 ISO Abbreviation: J. Card. Fail. Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-04-28 Completed Date: 2010-02-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9442138 Medline TA: J Card Fail Country: United States |
Other Details:
|
Languages: eng Pagination: 341-6 Citation Subset: IM |
Affiliation:
|
Section of Cardiac Surgery, Chang Gung Institute of Technology, Chia-Yi, Taoyuan, Taiwan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Algorithms* Disease Management Female Follow-Up Studies Heart Valve Prosthesis / standards Heart Valve Prosthesis Implantation / instrumentation, methods*, standards Humans Male Middle Aged Mitral Valve / pathology, surgery Mitral Valve Insufficiency / pathology*, surgery* Prosthesis Design / standards |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Accelerometer-based quantification of 6-minute walk test performance in patients with chronic heart ...
Next Document: Value of the paced QRS duration.